Evidence map›Paper›PMID 35022744›Full record

ArticleJournal of the National Cancer Institute2022

RE: Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report.

Junya Makiyama, Ryo Momosaki, Toshifumi Yodoshi, Takeshi Fujieda, Akihiro Ozaka, Atsushi Takayama, Takashi Yoshioka

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Response to Makiyama, Momosaki, Yodoshi, et al.Journal of the National Cancer Institute · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Junya MakiyamaDepartment of Hematology, Sasebo City General Hospital, Sasebo, Japan.ORCID 0000-0003-0883-2920
Ryo MomosakiDepartment of Rehabilitation Medicine, Mie University Graduate School of Medicine, Mie, Japan.ORCID 0000-0003-3274-3952
Toshifumi YodoshiDepartment of Clinical Research and Quality Management, University of the Ryukyus Graduate School of Medicine, Okinawa, Japan.
Takeshi FujiedaDepartment of Internal Medicine, Kitaibaraki City Hospital, Ibaraki, Japan.
Akihiro OzakaCenter for Innovate Research for Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima, Fukushima, Japan.
Atsushi TakayamaCenter for Innovate Research for Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima, Fukushima, Japan.ORCID 0000-0003-0479-3733
Takashi YoshiokaCenter for Innovate Research for  Communities and Clinical Excellence (CiRC2LE), Fukushima Medical University, Fukushima, Fukushima, Japan.ORCID 0000-0001-7709-8278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer SurvivorsFrailtyNeoplasmsChildCohort StudiesHumansSurvivors

Identifiers

PMID35022744
PMCPMC9194622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.